Immunological and clinical consequences of treating a patient with natalizumab.
Schwab N, Höhn KG, Schneider-Hohendorf T, Metz I, Stenner MP, Jilek S, Du Pasquier RA, Gold R, Meuth SG, Ransohoff RM, Brück W, Wiendl H.
Schwab N, et al. Among authors: metz i.
Mult Scler. 2012 Mar;18(3):335-44. doi: 10.1177/1352458511421919. Epub 2011 Sep 9.
Mult Scler. 2012.
PMID: 21908480